ZEISS Glaucoma Workplace
Software

ZEISS Glaucoma Workplace Simplifying the complex

Integrate individual data sets into a single visualization to help guide your assessments by spotlighting changes that could impact disease management.

  • Information delivery at a glance
  • Complete assessment based on a single display
  • Know sooner than later

What devices work with Glaucoma Workplace?

Glaucoma Workplace integrates data from multiple generations of HFA, allowing clinicians to take advantage of the latest test patterns and strategies, such as HFA3's 24-2C SITA Faster, while keeping all historical patient data in a single Guided Progression Analysis series.
ZEISS HFA3
Glaucoma Workplace integrates data from all generations of CIRRUS, including the new CIRRUS 60001, providing clinicians an uninterrupted view of their patient's structural progression.
ZEISS CIRRUS
Glaucoma Workplace offers support for review of CLARUS images, which offer an unparalleled view of the optic nerve head. In addition, Glaucoma Workplace also supports all third party DICOM-compatible fundus cameras.
ZEISS CLARUS
Zeiss Monitor your patient's progression

Monitor your patient's progression, at-a-glance.

The Progression Summary displays a quick at-a-glance summary of a patient’s detected progression.

In one click, the Progression Summary intelligently provides the Structure-Function Guided Progression Analysis (GPA) overview to show areas where change2 has been detected.

There are multiple challenges for the doctor managing glaucoma: first, is to accurately diagnose and stage glaucoma; and, second, to quickly identify progression in those patients where therapy has been insufficient.

Nathan Radcliffe MD
Zeiss Monitor

Complete assessment based on a single display

Structure-Function GPA integrates all longitudinal patient data from CIRRUS, HFA, fundus images, and IOP.

Monitor your patient’s treatment:
Trend and Event Analysis for both structure and function shows progression over time.

Easily identify change:
GPA flags and visualizes points that have changed beyond observed variability.

Analyze across generations of data:
Multiple generations of CIRRUS and HFA data can be used together in GPA, assuring full data continuity

Zeiss preperimetric

Know sooner than later

Preserving vision requires making the right decisions at the right time; making those decisions with confidence starts with detecting change as early as possible.

In this pre-perimetric case, structural change was detected by CIRRUS OCT 4 years prior to functional loss detection in the HFA visual fields; both modalities are essential in providing a full assessment.

Know sooner than later

Respond with confidence

Respond with confidence

Mark Important Clinical Events
Indicate intervention directly on patient trend analyses.

Customize GPA Parameters
Create dual baselines to monitor the rates of progression before and after intervention.

Ready to unlock the full potential of your clinic?

ZEISS Retina & Glaucoma Workflow

The ZEISS Humphrey Field Analyzer 3 could be just the beginning: Take your workflows to a new level and learn how our products and applications add value beyond the mere sum of their parts.

Downloads



    • Glaucoma Workflow Whitepaper Dr. Hazari India EN

      1 MB


Specifications

Minimum requirements for Glaucoma Workplace powered by FORUM

FORUM Version

Version 4.4

Processor

Intel Core™ i5-750 or similar

Free RAM

At least 10 GB

Free hard disc capacity

Minimum 8.0 GB free space on HDD

Screen resolution

Minimum screen resolution: 1680x1050 pixels; Recommended screen resolution: 1920x1080 pixels or higher

Operating System

ZEISS Glaucoma Workplace can now be installed on a second PC/ server where FORUM is not installed.

Get in touch with us!

Receive more information about the product and availability in your country!

Form is loading...

Personal contact information

If you want to have more information on data processing at ZEISS please refer to our data privacy notice


  • 1

    ZEISS CIRRUS 6000 is not available in the US and China.

  • 2

    Indicates change that exceeds test-retest variability.